| 1 |
Acne Vulgaris Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 2 |
Acromegaly - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 3 |
Actinic Keratosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 4 |
Acute Coronary Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 5 |
Allergic Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 6 |
Allergic Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 7 |
Alopecia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 8 |
Anesthetic Effect - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 9 |
Angina - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 10 |
Aplastic Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 11 |
Aspergillosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 12 |
Autism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 13 |
Bacteremia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 14 |
Bacterial (Pyogenic) Meningitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 15 |
Bacterial Pneumonia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 16 |
B-Cell Chronic Lymphocytic Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 17 |
B-Cell Lymphomas - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 18 |
Behcet's Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 19 |
Biliary Tumor - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 20 |
Bipolar Disorder (Manic Depression) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 21 |
Chemotherapy Induced Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 22 |
Chronic Kidney Disease (Chronic Renal Failure) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 23 |
Chronic Liver Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 24 |
Chronic Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 25 |
Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 26 |
Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 27 |
Hyperuricemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 28 |
Oral Mucositis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 29 |
Optic Neuritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 30 |
Opioid-Induced Constipation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 31 |
Open-Angle Glaucoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 32 |
Nosocomial Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 33 |
Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 34 |
Nasopharyngeal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 35 |
Myelofibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 36 |
Mycosis Fungoides - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 37 |
Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 38 |
Nocturia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 39 |
Myasthenia Gravis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 40 |
Metastatic Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 41 |
Metastatic Hepatocellular Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 42 |
Medullary Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 43 |
Malignant Mesothelioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 44 |
Male Hypogonadism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 45 |
Metastatic Renal Cell Carcinoma (mRCC) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 46 |
Anterior Uveitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 47 |
Bacterial Vaginosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 48 |
Blepharitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 49 |
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 50 |
Dyspepsia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 51 |
Endometriosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 52 |
Hereditary Angioedema - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 53 |
Venous Thromboembolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 54 |
Epithelial Ovarian Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 55 |
Erectile Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 56 |
Esophageal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 57 |
Febrile Neutropenia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 58 |
Fabry Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 59 |
Familial Amyloid Polyneuropathy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 60 |
Gastrointestinal Stromal Tumor (GIST) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 61 |
Gastric Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 62 |
Hairy Cell Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 63 |
Helicobacter Pylori Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 64 |
Hematopoietic Stem Cell Transplantation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 65 |
Hemophilia B - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 66 |
Hemostasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 67 |
Hepatitis D - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 68 |
Hypertriglyceridemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 69 |
Hot Flashes - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 70 |
Human papillomavirus (HPV) Associated Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 71 |
Idiopathic Pulmonary Fibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 72 |
Interstitial Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 73 |
Hypersomnia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 74 |
Hyperphosphatemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 75 |
Varicose Veins - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 76 |
Gastritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 77 |
Gastroparesis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 78 |
Idiopathic Short Stature - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 79 |
Infantile Spasm - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 80 |
Ischemic Stroke - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 81 |
Klebsiella Pneumoniae Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 82 |
Left Ventricular Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 83 |
Liposarcoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 84 |
Liver Failure - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 85 |
Moderate Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 86 |
Lupus Nephritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 87 |
Paroxysmal Nocturnal Hemoglobinuria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 88 |
Partial Seizure - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 89 |
Peanut Allergy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 90 |
Impetigo - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 91 |
Indolent Lymphoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 92 |
Influenza A Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 93 |
Waldenstrom Macroglobulinemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 94 |
Wet Macular Degeneration - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 95 |
Otitis Media - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 96 |
Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 97 |
Peptic Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 98 |
Insulin Resistance - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 99 |
Iron Deficiency Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 100 |
Short Bowel Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 101 |
Varicella Zoster (HHV-3) Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 102 |
Vancomycin-Resistant Enterococcus Faecium Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 103 |
Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 104 |
Peripheral T-Cell Lymphomas (PTCL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 105 |
Uveitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 106 |
Peripheral Neuropathic Pain - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 107 |
Pruritus - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 108 |
Tourette Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 109 |
Urinary Incontinence - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 110 |
Uterine Leiomyoma (Uterine Fibroids) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 111 |
Sarcoidosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 112 |
Sickle Cell Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 113 |
Sinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 114 |
Sleep Apnea - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 115 |
Smallpox - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 116 |
Soft Tissue Sarcoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 117 |
Spasticity - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 118 |
Spinal Muscular Atrophy (SMA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 119 |
Systemic Lupus Erythematosus - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 120 |
Systemic Juvenile Idiopathic Arthritis (SJIA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 121 |
Systemic Mastocytosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 122 |
Non-Small Cell Lung Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 123 |
Phenylketonuria (PKU) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 124 |
Rhinosinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 125 |
Rosacea - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 126 |
Seasonal Allergic Rhinitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 127 |
Secondary Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 128 |
Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 129 |
Sedation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 130 |
Seizures - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 131 |
Severe Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 132 |
Thrombocytopenia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 133 |
Thrombotic Thrombocytopenic Purpura - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 134 |
Polycystic Kidney Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 135 |
Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 136 |
Polycythemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 137 |
Traveler's Diarrhea - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 138 |
Pompe Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 139 |
Porphyria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 140 |
Post Menopausal Osteoporosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 141 |
Postherpetic Neuralgia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 142 |
Post-Traumatic Stress Disorder (PTSD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 143 |
Pouchitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 144 |
Premature Ejaculation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 145 |
Premature Labor (Tocolysis) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 146 |
Primary Biliary Cirrhosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 147 |
Primary Immune Deficiency (PID) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 148 |
Psoriatic Arthritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 149 |
Pulmonary Arterial Hypertension - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 150 |
Pulmonary Embolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 151 |
Pyelonephritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 152 |
Raynauds Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 153 |
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 154 |
Malignant Glioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 155 |
Relapsed Chronic Lymphocytic Leukemia (CLL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 156 |
Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 157 |
Renal Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 158 |
Restless Legs Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 159 |
Retinal Vein Occlusion - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
| 160 |
Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 |
Sample Page Link
|
